TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
STU:NKB2 (USA)   Ordinary Shares
€ 49.1 +0.80 (+1.66%) Jul 24
19.61
P/B:
14.72
Market Cap:
€ 7.54B ($ 8.59B)
Enterprise V:
€ 7.75B ($ 8.83B)
Volume:
600.00
Avg Vol (2M):
196.00
Trade In:

TG Therapeutics Inc (STU:NKB2) Dividend

TG Therapeutics Inc (STU:NKB2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -2%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:NKB2 Dividend

Does TG Therapeutics Inc (STU:NKB2) pay a dividend?

TG Therapeutics Inc (STU:NKB2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't TG Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. TG Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -2% over the past 3 years.

What are dividend-paying alternatives to TG Therapeutics Inc?

For dividend-paying alternatives in TG Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.